corilagin has been researched along with Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diao, Y; Li, B; Li, W; Liu, J; Mou, X; Wang, Y; Zheng, M | 1 |
| Diao, Y; Han, Q; Li, B; Liu, G; Liu, J; Wang, Y | 1 |
2 other study(ies) available for corilagin and Ischemia
| Article | Year |
|---|---|
Corilagin alleviates intestinal ischemia/reperfusion injury by relieving oxidative stress and apoptosis via AMPK/Sirt1-autophagy pathway.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Hydrolyzable Tannins; Ischemia; Oxidative Stress; Rats; Reperfusion Injury; Signal Transduction; Sirtuin 1 | 2023 |
Corilagin attenuates intestinal ischemia/reperfusion injury in mice by inhibiting ferritinophagy-mediated ferroptosis through disrupting NCOA4-ferritin interaction.
Topics: Animals; Ferritins; Ferroptosis; Ischemia; Mesenteric Ischemia; Mice; Molecular Docking Simulation; Reperfusion Injury | 2023 |